- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/78 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Patent holdings for IPC class C07D 333/78
Total number of patents in this class: 186
10-year publication summary
9
|
6
|
16
|
20
|
10
|
14
|
13
|
5
|
14
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Patent GmbH | 5864 |
16 |
Sumitomo Chemical Company, Limited | 9008 |
6 |
Enyo Pharma | 58 |
6 |
JSR Corporation | 2482 |
5 |
eFFECTOR Therapeutics, Inc. | 69 |
5 |
Osaka University | 3308 |
5 |
PGI Drug Discovery LLC | 27 |
4 |
Sunovion Pharmaceuticals Inc. | 290 |
4 |
Ryvu Therapeutics SA | 40 |
4 |
Syngenta Participations AG | 3029 |
3 |
Astellas Pharma Inc. | 1121 |
3 |
Duk San Neolux Co., Ltd. | 595 |
3 |
Promega Corporation | 560 |
3 |
Elanco Tiergesundheit AG | 439 |
3 |
UCB Biopharma SRL | 651 |
3 |
Jiangxi Jemincare Group Co., Ltd | 71 |
3 |
Shanghai Jemincare Pharmaceuticals Co., Ltd | 29 |
3 |
Golgi Neurosciences S.r.l. | 5 |
3 |
Samsung Display Co., Ltd. | 33019 |
2 |
LG Chem, Ltd. | 17662 |
2 |
Other owners | 100 |